tiprankstipranks
Trending News
More News >
Bioline RX Ltd Sponsored ADR (BLRX)
:BLRX
US Market
Advertisement

Bioline RX Ltd Sponsored ADR (BLRX) Ratios

Compare
2,529 Followers

Bioline RX Ltd Sponsored ADR Ratios

BLRX's free cash flow for Q4 2024 was $0.48. For the 2024 fiscal year, BLRX's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.27 1.10 4.87 5.91 2.15
Quick Ratio
2.04 1.06 8.73 5.91 2.15
Cash Ratio
0.64 0.10 0.99 1.34 1.58
Solvency Ratio
>-0.01 -1.17 -0.71 -2.06 -1.19
Operating Cash Flow Ratio
-2.31 -0.53 -2.46 -2.43 -2.18
Short-Term Operating Cash Flow Coverage
-6.91 -7.19 -13.33 -8.55 -7.51
Net Current Asset Value
$ 9.27M$ -3.52M$ 26.46M$ 44.10M$ -2.38M
Leverage Ratios
Debt-to-Assets Ratio
0.32 0.18 0.16 0.06 0.16
Debt-to-Equity Ratio
0.66 0.88 0.24 0.07 0.35
Debt-to-Capital Ratio
0.40 0.47 0.20 0.06 0.26
Long-Term Debt-to-Capital Ratio
0.27 0.33 0.15 0.00 0.11
Financial Leverage Ratio
2.09 4.83 1.50 1.20 2.15
Debt Service Coverage Ratio
0.64 -10.79 -5.43 -7.07 -5.02
Interest Coverage Ratio
-2.10 -23.18 -13.51 -25.18 -15.60
Debt to Market Cap
0.62 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.01 0.01 0.02 <0.01 0.04
Net Debt to EBITDA
0.55 -0.13 -0.06 0.33 0.42
Profitability Margins
Gross Profit Margin
64.90%23.08%0.00%0.00%0.00%
EBIT Margin
23.13%-1218.13%0.00%0.00%0.00%
EBITDA Margin
38.05%-1189.29%0.00%0.00%0.00%
Operating Profit Margin
-80.47%-1035.29%0.00%0.00%0.00%
Pretax Profit Margin
-15.21%-1262.79%0.00%0.00%0.00%
Net Profit Margin
-15.21%-1262.79%0.00%0.00%0.00%
Continuous Operations Profit Margin
-15.21%-1262.79%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%75.64%104.03%103.03%
EBT Per EBIT
18.90%121.97%85.57%109.19%130.94%
Return on Assets (ROA)
-7.81%-94.82%-24.71%-34.58%-65.41%
Return on Equity (ROE)
-23.93%-458.40%-37.12%-41.34%-140.41%
Return on Capital Employed (ROCE)
-60.98%-235.06%-44.38%-34.57%-62.56%
Return on Invested Capital (ROIC)
-51.95%-200.27%-32.38%-34.55%-59.16%
Return on Tangible Assets
-10.27%-123.52%-34.63%-47.15%-120.94%
Earnings Yield
-20.59%-1.50%-0.10%-0.05%-0.12%
Efficiency Ratios
Receivables Turnover
11.63 13.41 0.00 0.00 0.00
Payables Turnover
1.67 0.34 0.09 0.13 0.16
Inventory Turnover
2.37 1.89 -0.02 0.00 0.00
Fixed Asset Turnover
19.23 2.54 0.00 0.00 0.00
Asset Turnover
0.51 0.08 0.00 0.00 0.00
Working Capital Turnover Ratio
1.51 0.21 0.00 0.00 0.00
Cash Conversion Cycle
-32.75 -854.23 -26.89K -2.89K -2.31K
Days of Sales Outstanding
31.39 27.22 0.00 0.00 0.00
Days of Inventory Outstanding
154.29 193.08 -23.00K 0.00 0.00
Days of Payables Outstanding
218.43 1.07K 3.89K 2.89K 2.31K
Operating Cycle
185.68 220.30 -23.00K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.01 -0.02 -0.03 -0.04 -0.09
Free Cash Flow Per Share
-0.01 -0.02 -0.03 -0.04 -0.09
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-1.54K -76.12 -83.04 -243.02 0.00
Capital Expenditure Coverage Ratio
-1.54K -76.12 -83.04 -243.02 0.00
Operating Cash Flow Coverage Ratio
-2.35 -1.95 -2.13 -5.07 -3.02
Operating Cash Flow to Sales Ratio
-1.45 -4.71 0.00 0.00 0.00
Free Cash Flow Yield
-163.58%-0.04%-0.15%-0.04%-0.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.86 -66.54 -967.86 -1.92K -823.96
Price-to-Sales (P/S) Ratio
0.89 840.27 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
0.79 305.02 359.26 794.50 1.16K
Price-to-Free Cash Flow (P/FCF) Ratio
-0.61 -176.09 -687.81 -2.29K -1.10K
Price-to-Operating Cash Flow Ratio
-0.51 -178.40 -696.09 -2.29K -1.10K
Price-to-Earnings Growth (PEG) Ratio
-0.13 -0.49 22.94 29.47 24.90
Price-to-Fair Value
0.79 305.02 359.26 794.50 1.16K
Enterprise Value Multiple
2.88 -70.78 -640.88 -2.13K -1.16K
Enterprise Value
24.50M 60.51B 18.27B 54.09B 25.48B
EV to EBITDA
2.88 -1.06K -640.88 -2.13K -1.16K
EV to Sales
1.10 12.61K 0.00 0.00 0.00
EV to Free Cash Flow
-0.76 -2.64K -687.87 -2.29K -1.10K
EV to Operating Cash Flow
-0.76 -2.68K -696.16 -2.29K -1.10K
Tangible Book Value Per Share
<0.01 >-0.01 0.04 0.07 <0.01
Shareholders’ Equity Per Share
<0.01 0.01 0.07 0.10 0.09
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.24 -0.04 -0.03
Revenue Per Share
0.01 <0.01 0.00 0.00 0.00
Net Income Per Share
>-0.01 -0.06 -0.02 -0.04 -0.12
Tax Burden
1.00 1.00 0.76 1.04 1.03
Interest Burden
-0.66 1.04 1.08 1.09 1.31
Research & Development to Revenue
0.37 2.61 0.00 0.00 0.00
SG&A to Revenue
0.81 3.47 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.04 0.48 0.00 0.00 0.00
Income Quality
9.52 0.37 1.05 0.87 0.77
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis